NARCOLEPSY TYPE 1
Clinical trials for NARCOLEPSY TYPE 1 explained in plain language.
Never miss a new study
Get alerted when new NARCOLEPSY TYPE 1 trials appear
Sign up with your email to follow new studies for NARCOLEPSY TYPE 1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug shows promise for reducing narcolepsy sleep attacks
Disease control CompletedThis study tested an experimental medication called ALKS 2680 for people with narcolepsy type 1, a sleep disorder that causes severe daytime sleepiness and sudden muscle weakness (cataplexy). Researchers compared the drug against a placebo in 92 participants over 6 weeks to see i…
Matched conditions: NARCOLEPSY TYPE 1
Phase: PHASE2 • Sponsor: Alkermes, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC
-
New pill shows promise in controlling debilitating sleep disorder
Disease control CompletedThis Phase 3 study tested whether an oral medication called TAK-861 could help people with Narcolepsy Type 1. About 105 participants took either the real pill or a placebo for 12 weeks. Researchers measured if it improved their ability to stay awake during the day and reduced sud…
Matched conditions: NARCOLEPSY TYPE 1
Phase: PHASE3 • Sponsor: Takeda • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC
-
Headband at home could replace sleep lab for narcolepsy diagnosis
Diagnosis CompletedThis study tested whether a comfortable headband worn at home can accurately track sleep and wake patterns to help diagnose narcolepsy type 1 and other sleep disorders. Researchers compared the headband's readings against traditional overnight sleep lab tests in 78 adults being e…
Matched conditions: NARCOLEPSY TYPE 1
Sponsor: Beacon Biosignals • Aim: Diagnosis
Last updated Mar 19, 2026 14:56 UTC